HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Presenting neuropsychological testing profile of autopsy-confirmed frontotemporal lobar degeneration.

AbstractAIMS:
We aimed to investigate how neuropsychological test measures at presentation might differentiate frontotemporal lobar degeneration (FTLD) from Alzheimer's disease (AD).
METHODS:
We compared autopsy-confirmed FTLD and definite AD with Clinical Dementia Rating ≤1. Factor scores and t values of each neuropsychological test measure were compared between FTLD and AD patients. Logistic regression analyses were applied to identify independent predictors within test measures for the differentiation of FTLD from AD.
RESULTS:
Factor analyses showed that the memory domain was more severely impaired in AD than in FTLD, whereas the language and attention domains were more severely impaired in FTLD than in AD. Multiple logistic regression analysis showed that Letter Fluency, Boston Naming Test and delayed memory recall remained independent predictors of FTLD compared to AD. However, test measures did not discriminate between FTLD-tau and FTLD-ubiquitin.
CONCLUSION:
We confirm that memory and language function tests discriminate between FTLD and AD.
AuthorsHiroshi Yoshizawa, Jean Paul G Vonsattel, Lawrence S Honig
JournalDementia and geriatric cognitive disorders (Dement Geriatr Cogn Disord) Vol. 36 Issue 5-6 Pg. 279-89 ( 2013) ISSN: 1421-9824 [Electronic] Switzerland
PMID23949428 (Publication Type: Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2013 S. Karger AG, Basel.
Topics
  • Age of Onset
  • Aged
  • Alzheimer Disease (diagnosis, epidemiology)
  • Autopsy
  • Case-Control Studies
  • Causality
  • Cognitive Dysfunction (epidemiology)
  • Comorbidity
  • Diagnosis, Differential
  • Female
  • Frontotemporal Lobar Degeneration (diagnosis, epidemiology, pathology)
  • Humans
  • Male
  • Neuropsychological Tests
  • Retrospective Studies
  • Speech Disorders (epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: